NEW YORK (GenomeWeb News) – Bio-Rad Laboratories disclosed in its 10-Q filed this week that during the first quarter it acquired certain assets from a current raw material supplier for around $12.5 million. It didn't name the company, but also said that it paid $2 million for employment agreements as an incentive to certain employees of the acquired business to remain with Bio-Rad.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.